These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 33207872)

  • 1. Sensitive and Simultaneous Detection of SARS-CoV-2-Specific IgM/IgG Using Lateral Flow Immunoassay Based on Dual-Mode Quantum Dot Nanobeads.
    Wang C; Yang X; Gu B; Liu H; Zhou Z; Shi L; Cheng X; Wang S
    Anal Chem; 2020 Dec; 92(23):15542-15549. PubMed ID: 33207872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous Detection of SARS-CoV-2 IgG/IgM Antibodies, Using Gold Nanoparticles-Based Lateral Flow Immunoassay.
    Ahmadi A; Mirzaeizadeh Z; Omidfar K
    Monoclon Antib Immunodiagn Immunother; 2021 Oct; 40(5):210-218. PubMed ID: 34678096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development, performance evaluation, and clinical application of a Rapid SARS-CoV-2 IgM and IgG Test Kit based on automated fluorescence immunoassay.
    Kang K; Huang L; Ouyang C; Du J; Yang B; Chi Y; He S; Ying L; Chen G; Wang J
    J Med Virol; 2021 May; 93(5):2838-2847. PubMed ID: 33231312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasensitive and Simultaneous Detection of Two Specific SARS-CoV-2 Antigens in Human Specimens Using Direct/Enrichment Dual-Mode Fluorescence Lateral Flow Immunoassay.
    Wang C; Cheng X; Liu L; Zhang X; Yang X; Zheng S; Rong Z; Wang S
    ACS Appl Mater Interfaces; 2021 Sep; 13(34):40342-40353. PubMed ID: 34412466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of spike protein-based fluorescence lateral flow assay for the simultaneous detection of SARS-CoV-2 specific IgM and IgG.
    Wang C; Shi D; Wan N; Yang X; Liu H; Gao H; Zhang M; Bai Z; Li D; Dai E; Rong Z; Wang S
    Analyst; 2021 Jun; 146(12):3908-3917. PubMed ID: 33970172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EDTA-K
    Hu X; Wu C; Situ B; Tian P; An T; Li Q; Pan W; Zhang R; Yang B; Sun D; Hu Y; Wang Q; Zheng L
    Int J Nanomedicine; 2021; 16():715-724. PubMed ID: 33542626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis.
    Li Z; Yi Y; Luo X; Xiong N; Liu Y; Li S; Sun R; Wang Y; Hu B; Chen W; Zhang Y; Wang J; Huang B; Lin Y; Yang J; Cai W; Wang X; Cheng J; Chen Z; Sun K; Pan W; Zhan Z; Chen L; Ye F
    J Med Virol; 2020 Sep; 92(9):1518-1524. PubMed ID: 32104917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid, label-free, and sensitive point-of-care testing of anti-SARS-CoV-2 IgM/IgG using all-fiber Fresnel reflection microfluidic biosensor.
    Xu W; Liu J; Song D; Li C; Zhu A; Long F
    Mikrochim Acta; 2021 Jul; 188(8):261. PubMed ID: 34278534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.
    Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG
    Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ag Nanoparticles with Ultrathin Au Shell-Based Lateral Flow Immunoassay for Colorimetric and SERS Dual-Mode Detection of SARS-CoV-2 IgG.
    Liang P; Guo Q; Zhao T; Wen CY; Tian Z; Shang Y; Xing J; Jiang Y; Zeng J
    Anal Chem; 2022 Jun; 94(23):8466-8473. PubMed ID: 35657150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test.
    Kitagawa Y; Imai K; Matsuoka M; Fukada A; Kubota K; Sato M; Takada T; Noguchi S; Tarumoto N; Maesaki S; Takeuchi S; Maeda T
    J Med Virol; 2022 Jan; 94(1):335-341. PubMed ID: 34524695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical validation of a second generation anti-SARS-CoV-2 IgG and IgM automated chemiluminescent immunoassay.
    Pieri M; Nuccetelli M; Nicolai E; Sarubbi S; Grelli S; Bernardini S
    J Med Virol; 2021 Apr; 93(4):2523-2528. PubMed ID: 33463719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a smartphone-based quantum dot lateral flow immunoassay strip for ultrasensitive detection of anti-SARS-CoV-2 IgG and neutralizing antibodies.
    Li J; Liu B; Tang X; Wu Z; Lu J; Liang C; Hou S; Zhang L; Li T; Zhao W; Fu Y; Ke Y; Li C
    Int J Infect Dis; 2022 Aug; 121():58-65. PubMed ID: 35483554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a Lateral Flow Immunoassay COVIDTECH
    Exinger J; Hartard C; Lafferrière F; Fenninger C; Charbonnière LJ; Jeulin H
    Jpn J Infect Dis; 2022 Jul; 75(4):334-340. PubMed ID: 34980703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of the serological detection of IgG and IgM to SARS-Cov-2: a prospective, cross-sectional study.
    Pecoraro V; Cassetti T; Meacci M; Gargiulo R; Capobianchi MR; Mussini C; Vecchi E; Pecorari M; Gagliotti C; Trenti T; Sarti M
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1891-1898. PubMed ID: 33839972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Potential of a Luminex-Based Coronavirus Disease 2019 Suspension Immunoassay (COVID-19 SIA) for the Detection of Antibodies against SARS-CoV-2.
    Hoffman T; Kolstad L; Lindahl JF; Albinsson B; Bergqvist A; Rönnberg B; Lundkvist Å
    Viruses; 2021 May; 13(6):. PubMed ID: 34073484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
    Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
    Front Public Health; 2020; 8():620222. PubMed ID: 33681115
    [No Abstract]   [Full Text] [Related]  

  • 19. Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott).
    Charpentier C; Ichou H; Damond F; Bouvet E; Chaix ML; Ferré V; Delaugerre C; Mahjoub N; Larrouy L; Le Hingrat Q; Visseaux B; Mackiewicz V; Descamps D; Fidouh-Houhou N
    J Clin Virol; 2020 Nov; 132():104618. PubMed ID: 32919222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid and Sensitive Detection of anti-SARS-CoV-2 IgG, Using Lanthanide-Doped Nanoparticles-Based Lateral Flow Immunoassay.
    Chen Z; Zhang Z; Zhai X; Li Y; Lin L; Zhao H; Bian L; Li P; Yu L; Wu Y; Lin G
    Anal Chem; 2020 May; 92(10):7226-7231. PubMed ID: 32323974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.